Clinical and microbiologic characteristics of invasive Streptococcus pyogenes infections in north and south India

Journal of Clinical Microbiology

Volumn 50, Issue 5, 2012, Pages 1626-1631

  Haggar, Axana ^a   Nerlich, Andreas ^b   Kumar, Rajesh ^c   Abraham, Vinod J ^d   Brahmadathan, Kootallur N ^d   Ray, Pallab ^c   Dhanda, Vanita ^c   Joshua, John Melbin Jose ^d   Mehra, Narinder ^e   Bergmann, Rene ^b   Chhatwal, G Singh ^b   Norrby Teglund, Anna ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^d CHRISTIAN MEDICAL COLLEGE   (India)

^e ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

SUPERANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIUM ISOLATE; CELLULITIS; CHILD; COHORT ANALYSIS; DISEASE SURVEILLANCE; EMM GENE; FEMALE; GENETIC HETEROGENEITY; GEOGRAPHIC DISTRIBUTION; GROUP A STREPTOCOCCAL INFECTION; HUMAN; INDIA; INFANT; MAJOR CLINICAL STUDY; MALE; NECROTIZING FASCIITIS; NONHUMAN; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SEROLOGY; STREPTOCOCCUS PYOGENES; TOXIC SHOCK SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIBODIES, NEUTRALIZING; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HUMANS; INDIA; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; QUESTIONNAIRES; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SUPERANTIGENS; YOUNG ADULT;

EID: 84859965957     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.06697-11     Document Type: Article

References (30)

1. Aziz RK, Kotb M. 2008. Rise and persistence of global M1T1 clone of Streptococcus pyogenes. Emerg. Infect. Dis. 14:1511-1517.
2. Basma H, et al. 1999. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect. Immun. 67:1871-1877. (Pubitemid 29144409)
3. Bessen DE, Sotir CM, Readdy TL, Hollingshead SK. 1996. Genetic correlates of throat and skin isolates of group A streptococci. J. Infect. Dis. 173:896-900. (Pubitemid 26176012)
4. Brahmadathan KN, Koshi G. 1988. Epidemiology of streptococcal pyoderma in an orphanage community of a tropical country. J. Trop. Med. Hyg. 91:306-314. (Pubitemid 19036956)
5. Carapetis J, Steer AC, Mulholland EK, Weber M. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5:685-694. (Pubitemid 41505357)
6. Dale JB, Penfound TA, Chiang EY, Walton WJ. 2011. New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. Vaccine 29:8175-8178.
7. Darenberg J, et al. 2003. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome - an European randomized double-blind placebo-controlled trial. Clin. Infect. Dis. 37:333-340. (Pubitemid 36976489)
8. Davies DH, et al. 1996. Invasive group A streptococcal infections in Ontario, Canada. N. Engl. J. Med. 135:547-554.
9. Efstratiou A. 2000. Group A streptococci in the 1990s. J. Antimicrob. Chemother. 45:3-12. (Pubitemid 30093616)
10. Ekelund K, Skinhoj P, Madsen J, Konradsen HB. 2005. Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects. Clin. Microbiol. Infect. 11:569-576. (Pubitemid 40895158)
11. Hollm-Delgado M-G, Allard R, Pilon PA. 2005. Invasive group A streptococcal infections, clinical manifestations and their predictors, Montreal 1995-2001. Emerg. Infect. Dis. 11:77-82. (Pubitemid 40093356)
12. Jackson SJ, Steer AC, Campbell H. 2011. Systematic review: estimation of global burden of non-suppurative sequelae of upper respiratory tract infection: rheumatic fever and post-streptococcal glomerulonephritis. Trop. Med. Int. Health 16:2-11.
13. Kaul R, et al. 1999. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome - a comparative observational study. Clin. Infect. Dis. 28:800-807. (Pubitemid 29169419)
14. Kumar R, et al. 2009. Epidemiology of group A streptococcal pharyngitis & impetigo: a cross-sectional & follow up study in a rural community of northern India. Indian J. Med. Res. 130:765-771.
15. Lamagni TL, et al. 2008. Epidemiology of severe Streptococcus pyogenes disease in Europe. J. Clin. Microbiol. 46:2359-2367.
16. Le Hello S, et al. 2010. Clinical and microbial characteristics of invasive Streptococcus pyogenes disease in New Caledonia, a region in Oceania with a high incidence of acute rheumatic fever. J. Clin. Microbiol. 48:526-530.
17. Luca-Harari B, et al. 2009. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J. Clin. Microbiol. 47: 1155-1165.
18. Mascini EM, et al. 2000. Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies. J. Infect. Dis. 181:631-638. (Pubitemid 30131832)
19. Mathur P, et al. 2002. Invasive beta-haemolytic streptococcal infections in a tertiary care hospital in northern India. J. Med. Microbiol. 51:791-792.
20. McNeil SA, et al. 2005. Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers. Clin. Infect. Dis. 41:1114-1122. (Pubitemid 41429473)
21. Norrby-Teglund A, et al. 1998. Varying titres of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G (IVIG): implications for therapeutic efficacy. Clin. Infect. Dis. 26:631-638. (Pubitemid 28155011)
22. Norrby-Teglund A, Pauksens K, Holm SE, Norgren M. 1994. Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. J. Infect. Dis. 170:585-591. (Pubitemid 24262259)
23. O'Loughlin RE, et al. 2007. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin. Infect. Dis. 45:853-862. (Pubitemid 47580376)
24. Padmavati S. 2001. Rheumatic fever and rheumatic heart disease in India at the turn of the century. Indian Heart J. 53:35-37. (Pubitemid 33606407)
25. Sagar V, Kumar R, Ganguly NK, Chakraborti A. 2008. Comparative analysis of emm type pattern of group A Streptococcus throat and skin isolates from India and their association with closely related SIC, a streptococcal virulence factor. BMC Microbiol. 8:150.
26. Shet A, Kaplan E. 2004. Addressing the burden of group A streptococcal disease in India. Indian J. Pediatr. 71:41-48. (Pubitemid 38209263)
27. Steer AC, et al. 2009. Prospective surveillance of invasive group A streptococcal disease, Fiji, 2005-2007. Emerg. Infect. Dis. 15:216-222.
28. Steer AC, et al. 2009. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect. Dis. 9:611-616.
29. Vikerfors A, et al. 2009. Severe group A streptococcal infections in Uppsala County, Sweden: clinical and molecular characterization of a case cluster from 2006-2007. Scand. J. Infect. Dis. 41:822-830.
30. Working Group on Severe Streptococcal Infections. 1993. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA 269:390-391.